{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:33:46Z","timestamp":1792784026148,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007899","name":"University of Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007899","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pharmacology and Toxicology"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI119187"],"award-info":[{"award-number":["AI119187"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ejmech.2017.04.038","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T02:16:23Z","timestamp":1492654583000},"page":"70-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses"],"prefix":"10.1016","volume":"135","author":[{"given":"Yanmei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-4621","authenticated-orcid":false,"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.04.038_bib1","first-page":"1","article-title":"Antiviral strategies against influenza virus: towards new therapeutic approaches","author":"Loregian","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2017.04.038_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.med.51.1.407","article-title":"Global epidemiology of influenza: past and present","volume":"51","author":"Cox","year":"2000","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejmech.2017.04.038_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2017.04.038_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2017.04.038_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrmicro1208","article-title":"Influenza: lessons from past pandemics, warnings from current incidents","volume":"3","author":"Horimoto","year":"2005","journal-title":"Nat. Rev. Micro."},{"key":"10.1016\/j.ejmech.2017.04.038_bib6","series-title":"Textbook of Influenza","first-page":"20","article-title":"Influenza pandemics: history and lessons learned","author":"Monto","year":"2013"},{"key":"10.1016\/j.ejmech.2017.04.038_bib7","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMra1002842","article-title":"Influenza vaccines for the future","volume":"363","author":"Lambert","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2017.04.038_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep15279","article-title":"H3N2 mismatch of 2014-15 northern hemisphere influenza vaccines and head-to-head comparison between human and ferret Antisera derived antigenic maps","volume":"5","author":"Xie","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2017.04.038_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza vaccines: challenges and solutions","volume":"17","author":"Houser","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2017.04.038_bib10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/CMR.00097-12","article-title":"Traditional and new influenza vaccines","volume":"26","author":"Wong","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2017.04.038_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2017.04.038_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2017.04.038_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/jiq005","article-title":"Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008\u20132010","volume":"203","author":"Sheu","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2017.04.038_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/infdis\/jiq012","article-title":"Emerging influenza antiviral resistance threats","volume":"203","author":"Hayden","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2017.04.038_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.virol.2005.07.003","article-title":"Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia","volume":"341","author":"Ilyushina","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2017.04.038_bib16","doi-asserted-by":"crossref","first-page":"e16028","DOI":"10.1371\/journal.pone.0016028","article-title":"Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds","volume":"6","author":"Orozovic","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2017.04.038_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmech.2016.05.008","article-title":"Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel","volume":"120","author":"Arns","year":"2016","journal-title":"Eur. J. Med."},{"key":"10.1016\/j.ejmech.2017.04.038_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2016.01.005","article-title":"Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors","volume":"110","author":"Wang","year":"2016","journal-title":"Eur. J. Med."},{"key":"10.1016\/j.ejmech.2017.04.038_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.sbi.2010.12.002","article-title":"Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus","volume":"21","author":"Wang","year":"2011","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2017.04.038_bib20","doi-asserted-by":"crossref","first-page":"e0119115","DOI":"10.1371\/journal.pone.0119115","article-title":"Adamantane-resistant influenza a viruses in the world (1902\u20132013): frequency and distribution of M2 gene mutations","volume":"10","author":"Dong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2017.04.038_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/bip.22623","article-title":"Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza A viruses","volume":"104","author":"Wang","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejmech.2017.04.038_bib22","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/pro.2158","article-title":"Structural basis for proton conduction and inhibition by the influenza M2 protein","volume":"21","author":"Hong","year":"2012","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2017.04.038_bib23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2017.04.038_bib24","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1021\/acs.jmedchem.5b01910","article-title":"Discovery of highly potent inhibitors targeting the predominant drug-resistant S31N mutant of the influenza a virus M2 proton channel","volume":"59","author":"Li","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.04.038_bib25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/acsinfecdis.6b00130","article-title":"Discovery of potent antivirals against amantadine-resistant influenza a viruses by targeting the M2-S31N proton channel","volume":"2","author":"Li","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2017.04.038_bib26","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/acs.jmedchem.6b01852","article-title":"Expeditious lead optimization of isoxazole-containing influenza a virus M2-S31N inhibitors using the suzuki-miyaura cross-coupling reaction","volume":"60","author":"Li","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.04.038_bib27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1021\/jm3010114","article-title":"Organosilicon molecules with medicinal applications","volume":"56","author":"Franz","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.04.038_bib28","doi-asserted-by":"crossref","first-page":"13844","DOI":"10.1021\/ja2050666","article-title":"Exploring organosilane amines as potent inhibitors and structural probes of influenza a virus M2 proton channel","volume":"133","author":"Wang","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.04.038_bib29","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1021\/ol301933n","article-title":"Serine protease inhibition by a silanediol peptidomimetic","volume":"14","author":"Singh","year":"2012","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2017.04.038_bib30","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.1039\/c2cc32506c","article-title":"Hydrolytically stable octahedral silicon complexes as bioactive scaffolds: application to the design of DNA intercalators","volume":"48","author":"Xiang","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2017.04.038_bib31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1039\/C2CS35313J","article-title":"Far-red to near infrared analyte-responsive fluorescent probes based on organic fluorophore platforms for fluorescence imaging","volume":"42","author":"Yuan","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2017.04.038_bib32","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1021\/ja210375e","article-title":"Development of NIR fluorescent dyes based on Si\u2013rhodamine for in\u00a0vivo imaging","volume":"134","author":"Koide","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.04.038_bib33","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","article-title":"Neutral red uptake assay for the estimation of cell viability\/cytotoxicity","volume":"3","author":"Repetto","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2017.04.038_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2017.04.038_bib35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1021\/ja408712e","article-title":"Gold-catalyzed oxidative coupling of arylsilanes and arenes: origin of selectivity and improved precatalyst","volume":"136","author":"Ball","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.04.038_bib36","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1073\/pnas.0804958105","article-title":"Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel","volume":"105","author":"Jing","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2017.04.038_bib37","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1021\/bi9014488","article-title":"Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza a virus","volume":"48","author":"Balannik","year":"2009","journal-title":"Biochemistry"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417303021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417303021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T13:39:00Z","timestamp":1719149940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417303021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":37,"alternative-id":["S0223523417303021"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.038","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}